Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP.
- DOI
- 10.1016/j.dib.2020.106556
- Published
- 2021 Feb
- Container
- Data in brief
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.dib.2020.106556,
title = {Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP.},
author = {Faehling M and Schumann C and Christopoulos P and Hoffknecht P and Alt J and Horn M and Eisenmann S and Schlenska-Lange A and Schütt P and Steger F and Brückl WM and Christoph DC},
year = {2021},
journal = {Data in brief},
doi = {10.1016/j.dib.2020.106556},
url = {https://doi.org/10.1016/j.dib.2020.106556}
}RIS
TY - JOUR TI - Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP. AU - Faehling M AU - Schumann C AU - Christopoulos P AU - Hoffknecht P AU - Alt J AU - Horn M AU - Eisenmann S AU - Schlenska-Lange A AU - Schütt P AU - Steger F AU - Brückl WM AU - Christoph DC PY - 2021 JO - Data in brief DO - 10.1016/j.dib.2020.106556 UR - https://doi.org/10.1016/j.dib.2020.106556 ER -
APA
M, F., C, S., P, C., P, H., J, A., M, H., S, E., A, S., P, S., F, S., WM, B., & DC, C. (2021). Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP.. Data in brief. https://doi.org/10.1016/j.dib.2020.106556
Source records
- pubmed · retrieved 2026-09-26T00:48:25.846Z